Rtw Investments, LP Rocket Pharmaceuticals, Inc. Transaction History
Rtw Investments, LP
- $6.51 Billion
- Q2 2025
A detailed history of Rtw Investments, LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 17,687,772 shares of RCKT stock, worth $51.5 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
17,687,772
Previous 17,687,772
-0.0%
Holding current value
$51.5 Million
Previous $118 Million
63.27%
% of portfolio
0.67%
Previous 1.93%
Shares
9 transactions
Others Institutions Holding RCKT
# of Institutions
220Shares Held
98.4MCall Options Held
611KPut Options Held
474K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$24.3 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$17.8 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$14 Million0.17% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.14MShares$12.1 Million0.35% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $220M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...